Ligand Pharma (LGND) PT Raised to $144 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $288.82 -1.52%
Rating Summary:
14 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
14 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis raised the price target on Ligand Pharma (NASDAQ: LGND) to $144.00 (from $135.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
- Quanta Computer Inc. (2382:TT) (QUCPF) PT Raised to NT$626 at Nomura/Instinet
- Singapore Technologies Engineering (STE:SP) (SGGKF) PT Raised to SGD10.24 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
